Rekombinanter VEGFR2/CD309 Antikörper
Kurzübersicht für Rekombinanter VEGFR2/CD309 Antikörper (ABIN1589715)
Target
Alle VEGFR2/CD309 (VEGFR2) Antikörper anzeigenAntikörpertyp
Fragment
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Expressionssystem
- Escherichia coli (E. coli)
-
Verwendungszweck
- VEGFR-2/sc-Fv (single chain) antibody
-
Produktmerkmale
-
Anti-human VEGFR-2 single chain (VEGFR-2 sc-Fv) antibody was constructed from cDNA of mice immunized with highly purified soluble VEGFR-2 protein expressed in insect cells. Anti-human VEGFR-2 sc-Fv was produced in E. coli and affinity purified.
-
-
-
-
Applikationshinweise
- FACS: Use at 0.5-5 μg/mL, ELISA
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Frozen
-
Rekonstitution
- Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL.
-
Buffer
- 150 mM NaCl, 150 mM NaP, pH 7.2
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- The single chain antibody is supplied as frozen liquid (concentration please see vial label). For long time storage we recommend storage at -20°C to -70°C.
-
Haltbarkeit
- 24 months
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Andere Bezeichnung
- VEGFR-2
-
Hintergrund
- Vascular endothelial growth factor receptor-2 , KDR, FLK1, CD309, VEGF receptor 2, kinase insert domain protein receptor,Anti-human VEGFR-2 single chain (VEGFR-2 sc-Fv) antibody was constructed from cDNA of mice immunized with highly purified soluble VEGFR-2 protein expressed in insect cells. Anti-human VEGFR-2 sc-Fv was produced in E. coli and affinity purified.
-
Gen-ID
- 3791
-
NCBI Accession
- NM_002253, NP_002244
-
UniProt
- P35968
-
Pathways
- RTK Signalweg, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Target
-